Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors.
Wu MZ, Teng TK, Tsang CT, Chan YH, Lee CH, Ren QW, Huang JY, Cheang IF, Tse YK, Li XL, Xu X, Tse HF, Lam CSP, Yiu KH.
Wu MZ, et al.
Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):45-52. doi: 10.1093/ehjcvp/pvad081.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 37942588